European Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday Trading

MT Newswires Live05-12 23:14

European equities traded in the US as American depositary receipts were down significantly late Tuesday morning, dropping 1.05% to 1,814.06 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and 3D printer company Materialise (MTLS), which advanced 7.5% and 3.1% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and internet advertising firm Criteo (CRTO), which were up 1.5% and 1% respectively.

The decliners from continental Europe were led by accommodations booking site trivago (TRVG) and telecommunications company Nokia (NOK), which fell 5.2% and 4.3% respectively. They were followed by internet browser company Opera (OPRA) and semiconductor company Sequans Communications (SQNS), which dropped 1.9% and 1.8% respectively.

The gainers from the UK were led by cruise line operator Carnival (CUK) and tobacco company British American Tobacco (BTI), which climbed 6.6% and 2.4% respectively. They were followed by pharmaceutical company GSK (GSK) and biopharmaceutical company Mereo BioPharma Group (MREO), which rose 2% and 1.1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics (AKTX) and telecommunications operator Vodafone Group (VOD), which fell 22% and 8.4% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and lender Lloyds Banking Group (LYG), which lost 5.2% and 3.7% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment